FDA approval
Scope
Date
~
-
Bio & Pharma
S.Korea's FutureChem gets approval for phase 3 clinical trials in China
South Korean radiopharmaceutical development company FutureChem Co. announced on Thursday that China's National Medical Products Administration (NMP...
Mar 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Bio's pancreatic cancer treatment gets US FDA fast-track designation
Prestige Biopharma, a biopharmaceutical company in South Korea, announced on Thursday that their pancreatic cancer antibody drug, PBP1510 (Ulenistam...
Mar 16, 2023 (Gmt+09:00)
-
Robotics
Korean 3D tech firm Koh Young looks to US medical robot market
Koh Young Technology Inc., a South Korean developer of 3D optical inspection devices used in electronics manufacturing, is slated to enter the US me...
Mar 15, 2023 (Gmt+09:00)
-
Robotics
Curexo unveils artificial joint surgery robot TMAX at AAOS 2023
Curexo, a South Korean medical robot company, said on Tuesday that it had unveiled its artificial joint surgery robot "TMAX" at AAOS 2023, the world...
Mar 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong wins approval for GERD treatment Fexuclu in Chile
South Korean pharmaceutical company Daewoong Pharmaceutical announced on Tuesday that it has received marketing authorization from Chile's National ...
Mar 14, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma's licensed flu vaccine gets approval in Taiwan
South Korea's pharmaceutical firm GC Biopharma Corp. announced on Monday that its quadrivalent flu vaccine has received marketing approval from the ...
Mar 13, 2023 (Gmt+09:00)
-
Bio & Pharma
OliX's hair loss treatment candidate approved for clinical trial in Australia
South Korea's OliX Pharmaceuticals has received approval from Australia's Human Research Ethics Committees (HREC) to plan a phase 1 clinical trial o...
Mar 10, 2023 (Gmt+09:00)
-
Business & Politics
Korea clears environmental hurdle for new Jeju airport
South Korea’s environment ministry conditionally approved the construction of a new airport on Jeju Island with a 6.7 trillion won ($5.2 billi...
Mar 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Phase 3 clinical plan for SK Bioscience's booster shot approved in Colombia
SK Bioscience Co., a leading South Korean vaccine and biotech company, announced on Monday that its phase 3 clinical trial plan for a heterogeneous ...
Mar 07, 2023 (Gmt+09:00)
-
Energy
KHNP gets EUR certification for nuclear plant model in Europe
Korea Hydro & Nuclear Power (KHNP) on Thursday said the standard design of its APR1000, a nuclear power plant that it exports to Europe, has obt...
Mar 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong’s Nabota expands into Germany, Austria
South Korean drugmaker Daewoong Pharmaceutical Co. said on Tuesday it had launched its botulinum toxin product Nabota in Germany and Austria through i...
Mar 02, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Huons gets approval to supply anesthetics to Canada
Huons Co., a South Korean pharmaceutical company, has announced plans to expand its presence in the North American market by offering two anesthetic...
Feb 28, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Iljin Materials to change its name to Lotte Energy Materials
Lotte Chemical Corp., a South Korean petrochemical giant, will rename Iljin Materials Co., the country’s second-largest copper foil maker, as ...
Feb 28, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
BC Card shows one-stop payment int'l network at MWC 2023
BC Card, the only credit card company from South Korea taking part in this year's Mobile World Congress (MWC) in Barcelona, Spain, is displaying at ...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Jetema applies to test its botulinum toxin in US from July
South Korea's bio-esthetic pharmaceutical company Jetema Co. will hold clinical trials in the US to advance to the American market, the world's bigg...
Feb 27, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Turkey approves Hanwha Group's acquisition of DSME
The Turkish competition authority has approved Hanwha Group’s acquisition of Daewoo Shipbuilding & Marine Engineering Co. (DSME), the firs...
Feb 22, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma gets WHO pre-qualification approval for chickenpox vaccine
South Korea's GC Biopharma Corp. is set to regain the No. 1 spot in global production of chickenpox vaccines after earning qualification to enter th...
Feb 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea United Pharm signs contract to supply medicines to Saudi Arabia
Korea United Pharm. Inc. announced on Monday that it signed a contract to supply nine types of medicines, including 11 anticancer drugs, to Saudi ph...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Brazil approves Celltrion Pharm’s syringe facility
Celltrion Pharm Inc., a South Korean biopharmaceutical company, said on Monday it received certification from Brazil’s health regulator for it...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Hwajin Medical gets FDA sales approval for syringes
HLB Therapeutics Co. announced Thursday that Sofjec, a syringe produced by its subsidiary Hwajin Medical, has been approved for sale by the US Food ...
Feb 17, 2023 (Gmt+09:00)
-
Bio & Pharma
EOFlow's insulin injection pump starts to be sold in UAE
South Korea's medical device maker EOFlow Co. started selling the wearable insulin pump EOPatch in the United Arab Emirates.The company said on Tues...
Feb 15, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N's GERD drug K-CAB gets approval in Mexico
South Korea's biohealth company HK inno.N said on Tuesday that its gastroesophageal reflux disease (GERD) treatment K-CAB (active ingredient: tegopr...
Feb 14, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB’s Rivoceranib, Hengrui's Camrelizumab approved as combination therapy in China
South Korea's HLB Co. announced on Thursday that the combination therapy of its drug candidate rivoceranib and Jiangsu Hengrui Pharmaceuticals Co., ...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong receives approval for its GERD drug Fexuclue in Ecuador
Daewoong Pharmaceutical said Friday that it has obtained marketing authorization from Ecuador's National Agency for Health Regulation, Control and S...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience's SKYCellflu approved by Chilean health authority
SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, announced on Thursday that its world-first cell culture-based quadr...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Cell's AB-101 NK therapy achieves FDA fast-track status
South Korea's bio firm GC Cell announced on Wednesday that its US affiliate Artiva Biotherapeutics has received fast-track designation from the US F...
Feb 02, 2023 (Gmt+09:00)
-
Banking & Finance
Korea's credit card approval volume hit all-time high last year
The annual card approval amount in South Korea exceeded 1,000 trillion won ($811.4 billion) for the first time ever. This is largely because of "ret...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Nibec gets approval for its bone graft biomaterials in Colombia, Mexico
South Korea's bioactive peptide technology company Nibec Co. said on Friday that it has obtained product approval for the sale of two types of denta...
Jan 27, 2023 (Gmt+09:00)
-
Batteries
POSCO gets nod for battery technology transfer to overseas plants
POSCO Chemical Co., a unit of South Korean steelmaker POSCO Holdings Co., on Thursday won government approval to transfer technology to its overseas...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's botulinum toxin Nabota wins approval from Australia
Daewoong Pharmaceutical said on Wednesday that its botulinum toxin formulation Nabota (overseas brand name: Nuceiva) won approval in Australia on Ja...
Jan 26, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand